Clin2
NCT07608029Possibly a fitNot yet recruiting

Herbal granules for depression after a stem cell transplant

Depressive Disorder, SecondaryHematopoietic Stem Cell Transplantation

Part of Cancer, Mental health clinical trials.

This study tests whether an herbal product called Xiaochaihu granules can help treat depression that starts after a stem cell transplant. If you have post-transplant depression, this treatment might offer a new option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
46 people
Ages
14 years and older
Study type
Interventional

Who can take part

  • You are at least 14 years old.
  • You had a stem cell transplant using a donor's cells.
  • You were diagnosed with depression after the transplant.
  • You are not currently taking other antidepressants.
  • You do not have severe heart, lung, liver, or kidney problems, and you are not allergic to the study medicine.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07616544Not yet recruiting· Phase 3
Herbal granules after heart stent procedure

This trial tests whether a traditional Chinese herbal medicine called Qidan Xiaoke granules can help people who have had a heart stent placed. It aims to see if the granules improve recovery and reduce future heart problems.

NCT06749470Not yet recruiting· Phase 4
Herbal capsules for treating depression

This study tests an herbal capsule (Jieyu Chufan) for treating depression. It compares the capsule to a placebo (a pill with no active ingredient) to see if it helps reduce depressive symptoms.

NCT07854405Not yet recruiting
Chinese herbal granules with standard care for advanced colorectal cancer

This study tests whether adding a traditional Chinese medicine called Zhen-Qi-Jie-Du granules to usual palliative care can improve outcomes for people with advanced colorectal cancer. It aims to see if the combination offers extra benefits without causing more harm.

Nanjing, Jiangsu
NCT07785284Not yet recruiting
Shugan Jieyu capsules for depression

This study tests whether Shugan Jieyu capsules, a Chinese herbal medicine, can safely and effectively treat depression. It looks at how well the capsules work and any side effects, with the goal of offering an alternative treatment option.

Beijing
NCT07747194Enrolling by invitation
Acupuncture to prevent nausea and vomiting after stem cell transplant

This study tests whether acupuncture can reduce nausea and vomiting that often occur after a stem cell transplant. If you are scheduled for a transplant, this treatment might help you feel better during recovery.

Chengdu, Sichuan
NCT07163702Not yet recruiting· Phase 2
Xinglou Chengqi Granule for recent ischemic stroke

This study tests a traditional Chinese medicine granule called Xinglou Chengqi. It is for people who had an ischemic stroke (blocked blood vessel in the brain) within the last 7 days and have certain symptoms. The goal is to see if it helps recovery and is safe.

Richmond, British Columbia

Hear when a new Hematopoietic Stem Cell Transplantation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.